Search

Author/Creator Naylor, Maria L.

1. Bioequivalence of intramuscular and subcutaneous peginterferon beta-1a: results of a phase I, open-label crossover study in healthy volunteers. (January 2021)

Authors:
Zhao, Yuan; Chen, Kun; Ramia, Nancy; Sahu, Sangeeta; Kumar, Achint; Naylor, Maria L.; Zhu, Li; Naik, Himanshu; Butts, Cherié L.
Journal:
Therapeutic advances in neurological disorders
Issue:
Volume 14(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Long-term outcomes of peginterferon beta-1a in multiple sclerosis: results from the ADVANCE extension study, ATTAIN. (August 2018)

Authors:
Newsome, Scott D.; Scott, Thomas F.; Arnold, Douglas L.; Nelles, Gereon; Hung, Serena; Cui, Yue; Shang, Shulian; Naylor, Maria L.; Kremenchutzky, Marcelo
Journal:
Therapeutic advances in neurological disorders
Issue:
Volume 11(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Peginterferon β-1a every 2 weeks increased achievement of no evidence of disease activity over 4 years in the ADVANCE and ATTAIN studies in patients with relapsing–remitting multiple sclerosis. (August 2018)

Authors:
Arnold, Douglas L.; Shang, Shulian; Dong, Qunming; Meergans, Matthias; Naylor, Maria L.
Journal:
Therapeutic advances in neurological disorders
Issue:
Volume 11(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search